Farms.com Home   News

Porcine Circovirus Webinar Provides Timely Updates, SHIC Says

Porcine circovirus (PCV) presents a significant swine disease challenge, says the Swine Health Information Center (SHIC). That's why it is included in SHIC’s 2024 Plan of Work as a priority pathogen.

SHIC, along with the American Association of Swine Veterinarians, recently held a webinar focused on emerging trends of porcine circovirus. Expert presenters provided the latest information on porcine circovirus including domestic and global distribution, new research updates, diagnostic trends, sample types submitted for surveillance, interpretation of test results and practitioner perspectives for disease management strategies.  

Tanja Opriessnig of Iowa State University provided a general disease overview including domestic and global distribution, recent research outcomes and an update on PCV4. She said although PCVs were first identified approximately 27 years ago, an improved understanding of circoviruses and their impact on swine health has continued to evolve over time.  

"PCV2 has been a significant health challenge for global pig producers for many decades. Dr. Opriessnig said PCV2-specific vaccines have worked remarkably well to prevent viral health impacts since global introduction in 2006. Modern PCV2 vaccines provide cross-protection against currently known PCV2 genotypes and are among the most widely used vaccine in growing pigs. Dr. Opriessnig shared evidence of the global distribution of PCV3 as well as the recent identification of PCV4 in Asia and Spain, saying a more field-based approach is needed for prevention, preparedness, and response to emerging PCVs. Dr. Opriessnig remarked that initial evidence shows that PCV3 vaccines are helpful for control and that monitoring for emerging strains, including porcine circovirus-like viruses, is ongoing," SHIC reports in its latest newsletter.

Darin Madson of the Iowa State University Veterinary Diagnostic Lab (ISU VDL) said PCV2 is a globally distributed and ubiquitous virus with very few negative swine herds in the US. PCV2 ranks as one of the top three infectious agents in the swine industry. Madson explained that infection generally occurs after waning of maternal antibodies in pigs 7- to 15-weeks of age. Transmission of PCV2 is possible both horizontally (pig to pig) and vertically (dam to offspring) through nasal-oral and fecal-oral routes. He pointed out a major route of transmission occurs through virus secreted and/or excreted in urine, ocular discharge, nasal discharge, saliva and feces. Fomites capable of transmission include needles, insects, and rodents. Aerosol transmission of PCV2 is possible as the virus has been detected in exhaust air and dust outside barns; however, infectivity is unknown. 

During his presentation, Madson shared an AASV Board-approved porcine circovirus position statement to aid in accurate diagnosis of PCV.  

PCVAD can be subclinical or include one or more of the following clinical manifestations concurrently:

Click here to see more...

Trending Video

PRRS Eradication Strategies - Dr. DeBuse and Dr. Tousignant

Video: PRRS Eradication Strategies - Dr. DeBuse and Dr. Tousignant


In this episode of The Swine it Podcast Show, Dr. Neil DeBuse from Kalmbach Feeds and Dr. Steve Tousignant from Vaxxinova US discuss PRRS management strategies, recombination risks, whole genome sequencing, and the role of autogenous immunization programs in swine systems. They highlight practical approaches to improving immunity, reducing outbreaks, and advancing PRRS control across production systems. Listen now on all major platforms!

"Being PRRS negative sooner is a real key for eradication because every additional positive week increases production losses and viral exposure risks." - Dr. Neil DeBuse

Meet the guest: Dr. Neil DeBuse is a veterinarian at Kalmbach Feeds with more than 30 years of experience in swine health and production. His work focuses on PRRS control, biosecurity, immunity, and improving production stability across commercial swine systems in the United States and internationally.

Dr. Steve Tousignant is Director of the Swine Business Unit and Technical Services Veterinarian at Vaxxinova US, with a DVM and PhD from the University of Minnesota. His experience combines epidemiology, technical services, and practical immunization strategies designed to support consistent herd performance and long-term production stability. Don’t miss the chance to be part of the Swine Inner Circle!